Olmesartan Medoxomil
NDC 71209-080, Olmesartan Medoxomil, tablet, coated, from Cadila Pharmaceuticals Limited.
- Product NDC
- 71209-080
- Status
- Listed
- Labeler
- Cadila Pharmaceuticals Limited
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210682
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71209-080 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OLMESARTAN MEDOXOMIL20 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71209-080-01 | 71209008001 | 30 TABLET, COATED in 1 BOTTLE (71209-080-01) |
| 71209-080-04 | 71209008004 | 90 TABLET, COATED in 1 BOTTLE (71209-080-04) |
| 71209-080-10 | 71209008010 | 500 TABLET, COATED in 1 BOTTLE (71209-080-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c5416a9f-1dcc-4851-bbc0-6664d22fc8fa
Use it
Look up 71209-080 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71209-080 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71209-080. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.